Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

BGI-Shenzhen develops of calcium channel blockers

Nov. 11, 2016

TGFB1 may be behind coronary artery disease with glatiramer acetate treatment

Nov. 8, 2016

MERIT study of macitentan in CTEPH meets primary endpoint

Nov. 7, 2016

Researchers identify a novel locus for atrial fibrillation at TTN

Nov. 2, 2016

Serodus, Lam Therapeutics and Actelion receive FDA orphan designations for treatments in PAH

Oct. 27, 2016

Silvergate announces U.S. availability of Qbrelis

Oct. 27, 2016

Theravance Biopharma reports data from phase I MAD study of TD-0714

Oct. 27, 2016

NIH grant to support study of Capricor Therapeutics' CAP-2003

Oct. 21, 2016

Human Stem Cells Institute licenses Neovasculgen to ArtGen for development in the U.S. and Canada

Oct. 14, 2016

First patient enrolled in Reata Pharmaceuticals' phase III study of bardoxolone methyl

Oct. 7, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...